Christal Mickle
Founder at ZEVRA THERAPEUTICS, INC.
Net worth: 652 636 $ as of 30/06/2024
Christal Mickle active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Corporate Officer/Principal | 10/10/2023 | - |
| Founder | 30/10/2006 | - | |
| Director/Board Member | 30/10/2006 | 15/04/2015 | |
| Chief Executive Officer | 01/06/2023 | 10/10/2023 | |
| Chief Operating Officer | 30/10/2006 | 11/01/2023 | |
| Investor Relations Contact | 30/10/2006 | - | |
| Public Communications Contact | 18/09/2009 | - | |
| President | 01/06/2023 | 10/10/2023 | |
| Corporate Secretary | 30/10/2006 | - | |
| Treasurer | 30/10/2006 | - |
Career history of Christal Mickle
Former positions of Christal Mickle
| Companies | Position | Start | End |
|---|---|---|---|
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01/01/2002 | 01/01/2005 |
Training of Christal Mickle
| University of Virginia | Graduate Degree |
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
- Stock Market
- Insiders
- Christal Mickle
- Experience
